Time-dependent histamine release from stored human blood products

British Journal of Surgery

Volumn 83, Issue 2, 1996, Pages 259-262

  Nielsen, H J ^a   Edvardsen, L ^a   Vangsgaard, K ^a   Dybkjaer E ^a   Skov, P S ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Reference Laboratory   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ARTICLE; BLOOD STORAGE; BLOOD TRANSFUSION; HISTAMINE RELEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SAFETY;

BLOOD PRESERVATION; BLOOD TRANSFUSION; HISTAMINE; HISTAMINE RELEASE; HUMANS; RANDOM ALLOCATION; TIME FACTORS;

EID: 0030030656     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830236     Document Type: Article

References (41)

1. Nielsen HJ. Detrimental effects of perioperativc blood transfusion. Br J Surg 1995; 82: 582-7.
2. Jensen LS, Andersen AJ, Christiansen PM et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513-16.
3. Gafter U, Kalechman D, Sredni R. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992; 41: 143-8.
4. Wakefield CH, Carey PD, Foulds S, Monson JR, Guillou PJ. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80: 205-9.
5. 2 receptor antagonists as potential adjuvant treatment of malignant diseases. Advances in Bioscience 1993; 89: 319-34.
6. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Comparison of the effects of SAG-M and whole-blood transfusions on postoperative suppression of delayed hypersensitivity. Can J Surg 1991; 34: 146-50.
7. Blumberg N, Heal JM. Transfusion and host defenses against cancer recurrence and infection. Transfusion 1989; 29: 236-45.
8. Marsh J, Donnan PT, Hamer-Hodges DW, Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg 1990; 77: 623-6.
9. Busch ORC, Hop WCJ, Hoynck van Papendrect MAW, Marquet RL, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-6.
10. Ness PM, Walsh PC, Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992; 32: 31-6.
11. Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important? Dis Colon Rectum 1990; 33: 127-30.
12. Norrby K, Woolley D. Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumour tissue. Advances in Biosciences 1993; 89: 71-116.
13. Beer DJ, Rocklin RE. Histamine modulation of lymphocyte biology: membrane receptors, signal transduction, and functions. Crit Rev Immunol 1987; 7: 55-91.
14. Nielsen HJ, Hammer JH, Moesgaard F, Kehlet H. Ranitidine prevents postoperative transfusion-induced depression of delayed hypersensitivity. Surgery 1989; 105: 711-17.
15. Hermann K, Frank G, Ring J. Contamination of heparin by histamine: measurement and characterization by high-performance liquid chromatography and radioimmunoassay. Allergy 1994; 49: 569-72.
16. Sampson HA, Broadbent KR, Bernhisel-Broadbent J. Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989; 321: 328-32.
17. Grant JA, Alam R, Lett-Brown MA. Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991; 88: 683-93.
18. Bury TB, Corhay JL, Radermecker MF. Histamine-induced inhibition of neutrophil chemotaxis and T-lymphocyte proliferation in man. Allergy 1992; 47: 624-9.
19. Sitter H, Lorenz W, Klotter HJ, Duda D, Buess G, Sattler J. Elevated plasma histamine concentration as a sensitive real-time parameter for distinct phases of the surgical trauma: a tool for technology assessment. Agents Actions 1991; 33: 203-7.
20. Falus A, Merétey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992; 13: 154-6.
21. Brackett DJ, Hamburger SA, Lerner MR et al. An assessment of plasma histamine concentrations during documented endotoxic shock. Agents Actions 1990; 31: 263-74.
22. Liebman SM, Langer JC, Marshall JS, Collins SM. Role of mast cells in peritoneal adhesion formation. Am J Surg 1993; 165: 127-30.
23. Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L. Cimetidine preserves non-specific immune function after colonie resection for cancer. Aust N Z J Surg 1994; 64: 847-52.
24. Nielsen HJ. The effect of histamine type-2 receptor antagonists on posttraumatic immune competence. Dissertation. Dan Med Bull 1995; 42: 162-74.
25. Watson SA, Wilkinson LJ, Robertson JF, Hardcastle JD. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993; 34: 1091-6.
26. Adams WJ, Lawson JA, Morris DL. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 1994; 35: 1632-6.
27. 2 receptors on human melanoma cells. Biochem Biophys Res Commun 1988; 151: 518-23.
28. Tønnesen H, Knigge U, Bülow S et al. Effect of cimetidine on survival after gastric cancer. Lancet 1988; ii: 990-2.
29. Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet 1994; 344: 1768-9 (Letter).
30. Nielsen HJ, Hammer JH, Grønvall S et al. The effect of ranitidinc on immune function, tumor response and survival in patients with liver metastases from colorectal cancer. GI Cancer 1995 (in press).
31. Pearce FL. Biological effects of histamine: an overview. Agents Actions 1991; 33: 4-7 (Editorial).
32. Sipka S, Koltai M, Braquet P, Szegedi G. Histamine potentiates human platelet aggregation induced by platelet-activating factor. Int Arch Allergy Immunol 1992; 97: 89-92.
33. Blomberg J, Möller T, Olsson H, Anderson H, Jonsson M. Cancer morbidity in blood recipients - results of a cohort study. Eur J Cancer 1993; 29A: 2101-5.
34. Perttilä JT, Salo MS, Jalonen JR, Kuttilä KT, Viinamäki O, Pulkki KJ. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune responses to open heart surgery. Anesth Analg 1994; 79: 654-60.
35. Frewin DB, Jonsson JR, Head RJ, Russell WJ, Beal RW. Histamine levels in stored human blood. Transfusion 1984; 24: 502-4.
36. Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR. Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 1988; 114: 588-92.
37. Mennigen R, Kusche J, Krakamp B et al. Large bowel tumors and diamine oxidase (DAO) activity in patients: a new approach for risk group identification. Agents Actions 1988; 23: 351-3.
38. Linsalata M, Russo F, Cavallini A, Bercolo P, Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum 1993; 36: 662-7.
39. Högman CF, Gong J, Eriksson L, Hambraeus A, Johansson CS. White cells protect donor blood against bacterial contamination. Transfusion 1991; 31: 620-6.
40. Dzik WH. White cell-reduced blood components: should we go with the flow? Transfusion 1991; 31: 789-91.
41. Sprogøe-Jacobsen U, Sætre AM, Georgsen J. Preparation of white cell-reduced red cells by filtration: comparison of a bedside filter and two blood blank filter systems. Transfusion 1995; 35: 421-6.